FORWARD FEATURES CALENDAR

Managers

Specialist skin care supplier Essentially Yours secures GBP200,000 cash injection

Kidderminster-based skin care supplier Essentially Yours has secured GBP200,000 from the Midlands Engine Investment Fund (MEIF) West Midlands Debt Finance, managed by Maven Capital Partners (Maven), backed by the Coronavirus Business Interruption Scheme Loan (CBILS). The firm plans to use the funding to accelerate product development and expand its marketing

Foresight Energy Infrastructure Partners holds final close at EUR851.4m with a total capital pool in excess of EUR1.0 bn

Foresight Group (Foresight), a listed infrastructure and private equity manager group, has held the final close of Foresight Energy Infrastructure Partners (FEIP), a sustainability-led energy transition infrastructure fund investing predominantly in Europe.  FEIP has secured total commitments of EUR851.4 million, 70 per cent over the EUR500 million original target. The

Flexpoint Ford closes Flexpoint Asset Opportunity Fund II at USD825m

Flexpoint Ford, a private equity investment firm specialising in the financial services and healthcare industries, has held the final closing of its second asset investment fund, Flexpoint Asset Opportunity Fund II, (Asset Fund II), at USD825 million. Asset Fund II will build on the strategy established in the predecessor fund,

EMV Capital co-leads GBP12m investment round in Cambridge-based Martlet Capital with Saranac Partners

EMV Capital (EMVC) invested in Cambridge-based proposed deeptech early-stage investor Martlet Capital, alongside private office Saranac Partners and other investors. The investment enables Martlet Capital to complete the acquisition of a portfolio of 50-plus minority positions from Marshall Group, including companies in life science, healthcare, cleantech sustainability, industrial and semi-conductor

Startup Delegate Connect raises AUD10m in seed round

Delegate Connect, an end-to-end event platform, has raised AUD10 million in seed capital in its first ever funding round. The round is one of Australia’s largest Seed rounds, and for AirTree Ventures, who led the round, it’s the biggest Seed cheque written in the fund’s history. The round also includes

Compousoft acquires Access IT

Compusoft Group, a global visual CPQ provider, has acquired Access Information Technologies (Access IT), publishers of contractERP — an ERP solution tailored to the window & door and adjacent industries. The acquisition strengthens Compusoft’s offering to customers in the window & door industry by adding new capability to manage complex

Commonfund Capital closes third global private equity fund at USD236m

Commonfund Capital has held the closing of its third global private equity fund, Commonfund Capital Global Private Equity Partners III at USD236.6 million, above its prior global fund that closed at USD228.8 million.  The fund had strong participation from existing limited partners as well as a number of new investors;

CGE Partners invests in ethiXbase

CGE Partners (CGE) has invested in ethiXbase, a provider of third-party risk assessment services to corporates, focusing on anti-corruption, human rights, labour, and the environment. CGE is partnering with Leas Bachatene (CEO), Russell Potter (CFO) and Michelle Knight (Head of Operations) to back the company in its next phase of

AUA Private Equity-backed Westminster Pet Products acquires Pet ‘n Shape

AUA Private Equity Partners portfolio company Westminster Pet Products, has acquired substantially all of the assets of Pet Ventures, dba Pet ‘n Shape. Established in 2005 by the Abramson Family, Pet ‘n Shape is an emerging brand of pet treats and chews that offers a full-line of branded, high-quality products

Anjarium Biosciences raises CHF55.5m in Series A financing

Biotech company Anjarium Biosciences (Anjarium) has closed a CHF55.5 million (USD61 million) Series A financing, co-led by Abingworth and Gimv, with significant participation from Omega Funds, Pfizer Ventures and Surveyor Capital (a Citadel company).  Anjarium’s innovative approach leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology

Events

12 November, 2026 – 5:00 pm

Directory Listings